The long-term goal of this application has been to understand how autoreactive B cell responses are prevented in healthy individuals and how they are initiated and sustained in autoimmune disease. Specifically, B cells that produce anti-dsDNA antibodies (Abs) are studied. These Abs are highly significant clinically;they are one of the diagnostic criteria of the autoimmune disease Systemic Lupus Erythematosus (SLE), and they have been implicated in mediating tissue pathology. The approach has been to develop a transgenic (Tg) model using a heavy chain-only Tg (VH3H9) that can pair with endogenous light chains to generate both anti-DNA and non-DNA Abs. Here, the development of anti-dsDNA B cells can be tracked in the context of a diverse B cell repertoire in non-autoimmune and autoimmune-prone backgrounds. Taking this strategy, anti-dsDNA Abs are undetectable in the serum of BALB/c mice, yet the autoreactive B cells persist in the bone marrow and periphery with a phenotype indicative of antigen-mediated developmental arrest. In contrast, in autoimmune animals they are mature and by ten weeks of age autoAbs are detectable in the serum.
Specific aims of this competitive renewal are to compare and contrast the differentiation and activation potential of anti-dsDNA B cells from non-autoimmune and autoimmune mice. The impact of signal strength on B cell differentiation pathways will be investigated using low avidity naive, TH1 and TH2 effectors. The ability of bystander T cell activation to influence anti-dsDNA B cell fate will be explored. Having demonstrated that T regulatory cells can suppress the ability of T cell help to drive autoAb production in vivo, the mechanism behind this suppression will be investigated. The extent of anti-dsDNA B cell activation and differentiation following T-independent stimulation will also be assessed both in vitro and in vivo. Specifically, the functional capabilities of B cells exposed to TLR4 and TLR9 ligands will be investigated. It is hoped that through a better understanding of autoreactive B cell activation thresholds, and the differentiation pathways that ensue as a consequence of this activation, that more rational therapeutic strategies for treating autoimmune diseases will be developed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI032137-18
Application #
7533448
Study Section
Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section (HAI)
Program Officer
Peyman, John A
Project Start
1991-12-01
Project End
2010-11-30
Budget Start
2008-12-01
Budget End
2010-11-30
Support Year
18
Fiscal Year
2009
Total Cost
$511,566
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Hondowicz, Brian D; Batheja, Amrita O; Metzgar, Michele H et al. (2010) ICOS expression by effector T cells influences the ability of regulatory T cells to inhibit anti-chromatin B cell responses in recipient mice. J Autoimmun 34:460-8
Hondowicz, Brian D; Batheja, Amrita O; Metzgar, Michele H et al. (2009) Efficient help for autoreactive B-cell activation requires CD4+ T-cell recognition of an agonist peptide at the effector stage. Eur J Immunol 39:2377-82
Mandik-Nayak, Laura; Ridge, Natalie; Fields, Michele et al. (2008) Role of B cells in systemic lupus erythematosus and rheumatoid arthritis. Curr Opin Immunol 20:639-45
Hondowicz, Brian D; Fields, Michele L; Nish, Simone A et al. (2008) Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity. J Autoimmun 31:98-109
Fields, M L; Sokol, C L; Eaton-Bassiri, A et al. (2001) Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol 167:2370-8
Mandik-Nayak, L; Nayak, S; Sokol, C et al. (2000) The origin of anti-nuclear antibodies in bcl-2 transgenic mice. Int Immunol 12:353-64
Mandik-Nayak, L; Seo, S j; Eaton-Bassiri, A et al. (2000) Functional consequences of the developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J Immunol 164:1161-8
Eaton-Bassiri, A S; Mandik-Nayak, L; Seo, S J et al. (2000) Alterations in splenic architecture and the localization of anti-double-stranded DNA B cells in aged mice. Int Immunol 12:915-26
Noorchashm, H; Bui, A; Li, H L et al. (1999) Characterization of anergic anti-DNA B cells: B cell anergy is a T cell-independent and potentially reversible process. Int Immunol 11:765-76
Choi, Y; Ramnath, V R; Eaton, A S et al. (1999) Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Clin Immunol 93:34-45

Showing the most recent 10 out of 15 publications